A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions:   Breast Cancer;   Glioblastoma;   Head and Neck Squamous Cell Carcinoma;   Malignant Mesothelioma;   Non-small Cell Lung Cancers;   Sarcoma Intervention:   Drug: PRT3645 Sponsor:   Prelude Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Condition:   Pleural Mesothelioma Intervention:   Device: TTFields Sponsor:   NovoCure GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials

Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma
Conditions:   Malignant Pleural Mesothelioma;   Chemotherapy Effect Intervention:   Procedure: hyperthermic intrathoracic chemotherapy Sponsor:   Ain Shams University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2022 Category: Research Source Type: clinical trials